why choose us

First received: November 11, 2022

Clinical Trial: Drug-drug Interaction Study Beteewn ASK120067 and Rifampicin or Itraconazole

Study Status: Completed

Recruit Status: Completed

Condition: Locally Advanced or Metastatic NSCLC

Study Type: Interventional


Official Title: An Open-lable, Two- Period, Single-sequence, Self-controlled Study to Evaluate the Effect of Oral Rifampicin or Itraconazole on the Pharmacokinetics of ASK120067 Tablets

Brief Summary: To evaluate the effects of oral administration rifampicin or itraconazole capsules on the pharmacokinetics of ASK120067 and its metabolite CCB4580030 in healthy subjects.To evaluate the safety of ASK120067 tablets or combination with rifampicin capsules or itraconazole capsules in healthy subjects.

Read more